Effects of Exercise During Pregnancy on the Long-term Metabolic Health of Mothers and Their Offspring

February 21, 2026 updated by: Wang Chen, Peking University First Hospital

Long-Term Effects of Exercise During Pregnancy on the Metabolic Health of Mothers and Their Offspring: An 8- to 10-year Follow-Up Study

The aim of this study was to assess the long-term metabolic effects of gestational exercise on overweight and obese women and their offspring 8-10 years post-intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

We conducted a follow-up study of a randomized controlled trial (RCT) in which the impact of prenatal exercise on the incidence of gestational diabetes mellitus (GDM) was investigated. Mother-offspring pairs underwent comprehensive metabolic evaluations, including anthropometric measurements (weight, skinfold thickness, and body composition), blood pressure assessment, oral glucose tolerance tests (OGTTs), insulin release tests (IRTs), and lipid profiling.

Study Type

Observational

Enrollment (Actual)

221

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China, 100034
        • Peking University First Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This follow-up of a randomized trial included 300 overweight/obese pregnant women (prepregnancy BMI ≥24, <12⁺⁶ weeks gestation) from Peking University First Hospital (Dec 2014-Apr 2017). They were randomized to an exercise group (n=150, cycling three times/week, ≥30 min/session) or control group (n=150, usual activities). After excluding those who missed the OGTT (18 exercise, 17 control), 132 and 133 mother-offspring pairs, respectively, were included.

Description

Inclusion Criteria:

- 132 mothers in the exercise group and 133 mothers in the control group in the previous RCT trial who had OGTT results and their offsprings were eligible for follow-up

Exclusion Criteria:

- The criteria for exclusion from the follow-up study included loss to follow-up, refusal to participate, or major illness (acute lymphoblastic leukemia) of the mother or the child.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
exercise group
We conduct a follow-up study of a randomized controlled trial (RCT) in which the impact of prenatal exercise on the incidence of gestational diabetes mellitus (GDM) was investigated. Mother-offspring pairs underwent follow up
The present study is a prospective follow-up of a randomized controlled trial (RCT) that was conducted in the Department of Obstetrics and Gynecology, Peking University First Hospital, from December 2014 to April 2017. In this RCT, 300 obese/overweight pregnant women (prepregnancy BMI ≥24 kg/m²) at <12+6 weeks of gestation were randomized to exercise (n=150) and control groups (n=150), and the efficacy of regular exercise in early pregnancy to prevent GDM among overweight/obese pregnant Chinese women was investigated. The patients allocated to the exercise group were assigned to a cycling program (3 times per week, at least 30 min/session, rating of perceived exertion 12-14); the program was initiated within 3 days of randomization and continued until 37 weeks of gestation. The patients in the control group maintained their usual daily activities. The original RCT has been reported previously (Wang, C.Am. J. Obstet. Gynecol. 2017, 216 (4), 340-351.)
control group
We conduct a follow-up study of a randomized controlled trial (RCT) in which the impact of prenatal exercise on the incidence of gestational diabetes mellitus (GDM) was investigated. Mother-offspring pairs underwent follow up

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
OGTT
Time Frame: 8-10 years
75-g oral glucose tolerance test (0h,2h,mmol/L)
8-10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: 8-10 years
weight in kilograms, height in meters, and weight and height will be combined to report BMI in kg/m2
8-10 years
anthropometric measures
Time Frame: 8-10 years
anthropometric measurements include waist circumference and skinfold thickness (centimeters) using skinfold caliper. Additionally,And use a body composition analyzer to measure body fat content and distribution ( The fat mass [kg]; fat percentage [%]; visceral fat area [cm2]; and lean mass [kg] were determined using bioimpedance analysis).
8-10 years
insulin resistance
Time Frame: 8-10 years
plasma insulin levels were measured using electrochemiluminescence, and insulin resistance was calculated via the HOMA equation (fasting plasma insulin concentration (μIU/mL) × fasting glucose concentration (mmol/L)/22.5).
8-10 years
lipid profile
Time Frame: 8-10 years
fasting lipid profiles, including total cholesterol (TCHO), triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured via the cholesterol oxidase method (mmol/L)
8-10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chen Wang, Peking University Frist hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Actual)

November 15, 2024

Study Completion (Actual)

November 15, 2024

Study Registration Dates

First Submitted

February 17, 2026

First Submitted That Met QC Criteria

February 21, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 21, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Health

Clinical Trials on exercise

Subscribe